Add to Favorites Newsroom RSS Share
Philadelphia, PA USA

Our News on Newswise

Wistar Scientists Develop Novel Immunotherapy Technology for Prostate Cancer

A study led by Wistar scientists describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific protein.
17-Aug-2017 9:05 AM EDT Add to Favorites

New Therapeutic Approach for Difficult-to-Treat Subtype of Ovarian Cancer Identified

A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology
21-Jul-2017 3:05 PM EDT Add to Favorites

The Wistar Institute Appoints Two New Board Members


Wistar recently appointed John Fry and Morton Collins, Ph.D., to its Board of Trustees.
13-Jul-2017 3:05 PM EDT Add to Favorites

Synthetic DNA-Based Zika Vaccine Protects Against Damage to Testes in Preclinical Models


While the Zika virus is primarily transmitted by mosquitoes, research has shown that the disease can affect semen and sperm and can therefore be spread through sexual intercourse.
11-Jul-2017 10:30 AM EDT Add to Favorites

Wistar Welcomes Brian Keith, Ph.D., as the First-ever Dean of Biomedical Studies


Wistar announces the appointment of Brian Keith, Ph.D., as Dean of Biomedical Studies. This new, strategic position will further Wistar’s educational mission to train scientists and continue priming workforce development programs and...
7-Jul-2017 9:30 AM EDT Add to Favorites

The Wistar Institute Welcomes Chi Van Dang, M.D., Ph.D., as Professor


Wistar is pleased to announce the appointment of world-renowned scientist, medical oncologist and National Academy of Medicine member Chi Van Dang, M.D., Ph.D., as professor.
5-Jul-2017 11:05 AM EDT Add to Favorites

Wistar’s New Biomedical Research Technician Training Program Obtains First State Approval as Non-Traditional Apprenticeship to Support Region’s Life Sciences Workforce


Wistar's Biomedical Research Technician (BRT) Apprenticeship has become the first-ever registered, nontraditional apprenticeship program in biomedical research approved by the Pennsylvania Department of Labor & Industry.
30-May-2017 2:30 PM EDT Add to Favorites

The Wistar Institute Appoints Daniel W. Kulp, Ph.D., as Associate Professor in the Vaccine Center and Translational Tumor Immunology Program


The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, announces the appointment of Daniel W. Kulp, Ph.D., as associate professor in the Vaccine Center and the Translational Tumor Immunology...
11-May-2017 9:00 AM EDT Add to Favorites

Our YouTube Videos

Chat now!